Key facts
- Sanome’s last known valuation is $12.6M (Jan 2025).
- It has raised $2.5M; the latest was Early Stage VC ($2.5M) in Jan 2025.
- Notable investors include Heal Capital, Omron, THENA Capital.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Sanome
- ·The full record, as it builds
Funding rounds
No funding rounds for Sanome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sanome
Developer of a real-time, clinically integrated platform designed to provide a comprehensive view of individual health to support proactive and preventative care. The company offers real-time analysis of clinical records through unique data access agreements and integration with major Electronic Patient Record / Electronic Medical Record systems, enabling health systems to use artificial intelligence-enabled clinical decision support tools that fit into clinical workflows for earlier risk detection and faster decision-making.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 23
- Website
- sanome.com/
- Ownership
- Privately Held (backing)
Sanome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sanome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sanome in its N-PORT filings yet. We sweep new filings monthly.